SELLAS Life Sciences Group, Inc. Common Stock

SLSNASDAQ • USD
7.47 USD
↘ 0.39 (4.96%)AT CLOSE (03:59 PM EST)
8.36
↗ 0.89 (11.85%)
POST MARKET (AS OF 07:00 PM EST)
Post Market
AS OF 07:00 PM EST
8.36
↗ 0.89 (11.85%)
🟢Market: OPEN

SELLAS Life Sciences Group, Inc. Common Stock (SLS) trades at $8.36 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, SLS is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 16, 2026.

Open?$7.74
High?$8.39
Low?$7.24
Prev. Close?$7.86
Volume?7.9M
Avg. Volume?6.9M
VWAP?$7.64
Rel. Volume?1.15x
Bid / Ask
Bid?$6.41 × 100
Ask?$8.53 × 100
Spread?$2.12
Midpoint?$7.47
Valuation & Ratios
Market Cap?1.6B
Shares Out?201.9M
Float?199.3M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?12.16
EPS?-$0.18
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Employees
13
Market Cap
1.6B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2008-03-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: (646) 200-5278
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
31
Piotroski F-Score?0/9Weak
Altman Z-Score?100.70Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?28.66%Squeeze Risk
Short Interest?57.1M
Days to Cover?6.7
Free Float199.3M
Avg Daily Volume8.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?14.92Strong
Quick Ratio?14.92Strong
Cash Ratio?14.51Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
16
12.16HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-37.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-27.1%WEAK▾
ROA?
S&P
3
-25.4%WEAK▾
Cash Flow & Enterprise
FCF?$-27295000
Enterprise Value?$1.5B
Fundamentals ratios updated end of day